logo

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Alivus Life Sciences Share Price

ALIVUS

₹1,445

-4.90(-0.34%)
20th Nov 2026 | 3:28 PM
NSE : ALIVUS

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Alivus Life Sciences Share Price Today

As of 20-11-2026 18:06, Alivus Life Sciences Ltd. share price today is ₹0, with a change of ₹-1449.90 (-100.00%) from the previous close of ₹1449.9. The stock opened at ₹1449.9 and traded between ₹1420.4 and ₹1460, with a total traded volume of 143100 shares. The company has a market capitalization of ₹17829 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1574 and ₹819, respectively.

Alivus Life Sciences Ltd. valuation metrics include a P/E ratio of 26.6, and book value of ₹5.10. Profitability indicators show ROE of 16.94% along with a dividend yield of 0.3%. Alivus Life Sciences Ltd. has reported revenue of ₹2684.41 Cr and net profit of ₹669.74 Cr.

Alivus Life Sciences Ltd. technical indicators include Day RSI at 54.58, Day MFI at 37.54, Day ADX at 16.58. Additional indicators include Commodity Channel Index (CCI) at 20.3 and Williams %R at -72.7. Momentum indicators show Day MACD at 25.17, Day MACD Signal Line at 29.5, DayATR at 61.45. Rate of Change indicators for Alivus Life Sciences Ltd. include ROC125 at 37.24 and ROC21 at 15.26.

Exponential moving averages include EMA5 at ₹1451.4, EMA10 at ₹1452.4, EMA12 at ₹1449.8, EMA20 at ₹1435, EMA26 at ₹1424.6, EMA50 at ₹1390.2, EMA100 at ₹1320.4, EMA200 at ₹1217.3. Simple moving averages include SMA5 at ₹1450.3, SMA10 at ₹1466.4, SMA20 at ₹1434, SMA30 at ₹1394.2, SMA50 at ₹1387.8, SMA100 at ₹1322.8, SMA150 at ₹1236.3, SMA200 at ₹1164.1.

Support levels for Alivus Life Sciences are placed at First Support ₹1438.37, Second Support ₹1426.83, Third Support ₹1412.17. Resistance levels are seen at First Resistance ₹1464.57, Second Resistance ₹1479.23, Third Resistance ₹1490.77. Alivus Life Sciences Ltd. shareholding pattern shows promoter holding at 74.85%, FII holding at 5.93%, DII holding at 0%, public holding at 12.19%.

Alivus Life Sciences Performance

Price Movement

₹1445.00

₹1420.40

₹1460.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1445.00

₹819.00

₹1574.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,460.00
Low₹1,420.40
Open at₹1,449.90
Prev Close₹1,449.90
Volumes1.43 L
Avg Price₹1,438.91
Lower Circuit₹1,160.00
Upper Circuit₹1,739.80

Historical Performance

3M High₹1,574.00
3M Low₹1,208.10
1 Yr High₹1,574.00
1 Yr Low₹819.00
3 Yr High₹1,574.00
3 Yr Low₹620.20
5 Yr High₹1,574.00
5 Yr Low₹370.00

Alivus Life Sciences Fundamentals

Market Cap
High in industry
17,829 Cr.
PE Ratio (TTM)
Above industry Median
26.60
Dividend Yield
Below industry Median
0.30
Net Profit TTM
26.3% incr over last year
669.74
Net Profit Growth
26.3% incr over last year
669.74
PEG Ratio
Above industry Median
1
ROE
2% decr over last year
16.94
Operating Revenue TTM
2,684.41
Operating Revenue Growth
8.2% incr over last year
Book Value
Above industry Median
5.10
MFI
MFI is mid-range
37.54
RSI
RSI is mid-range
54.58
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
5.10

Alivus Life Sciences Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Sep 2026
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Total Revenue681.99640.41689.12672.89587.98
Operating Expense416.80428.70474.59441.62408.81
Operating Profit265.19211.71214.53231.27179.17
Depreciation21.8220.5820.2019.6618.44
Interest1.311.311.311.491.32
Tax65.2352.1553.1448.1344.11
Net Profit196.74160.08162.66150.26130.03

Alivus Life Sciences Technicals

Alivus Life Sciences Ltd. EMA & SMA

₹1445.00

0.30 (0.02%)

↗ Bullish Moving Average

12

↘ Bearish Moving Average

4

Day EMA5 ₹1451.4
Day EMA10 ₹1452.4
Day EMA12 ₹1449.8
Day EMA20 ₹1435
Day EMA26 ₹1424.6
Day EMA50 ₹1390.2
Day EMA100 ₹1320.4
Day EMA200 ₹1217.3

Alivus Life Sciences Support and Resistance

Resistance

First Resistance₹1464.57
Second Resistance₹1479.23
Third Resistance₹1490.77

Support

First Support₹1438.37
Second Support₹1426.83
Third Support₹1412.17

Technical Indicators

Day RSI54.58
Day MFI37.54
Day ADX16.58
Day Commodity Channel Index20.30
William-72.70
Day MACD25.17
Day MACD Signal Line29.50
Day ATR61.45
Day ROC12537.24
Day ROC2115.26

Alivus Life Sciences Shareholding Pattern

Held ByJun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoter74.974.974.974.974.974.8
FII6.46.85.15.35.55.9
DII5.65.57.17.37.27.1
Public1312.812.912.612.412.2

Alivus Life Sciences Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day1.34 L2.2 L60.76%
Week2.04 L4.17 L48.90%
1 Month3.09 L5.79 L53.43%
6 Month1.18 L2.27 L52.10%

Alivus Life Sciences SWOT Analysis

Strengths23
Weakness7
Opportunity3
Threats2

Companies with no Debt

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Negative to Positive growth in Sales and Profit with Strong Price momentum

Top Gainers

Stocks near 52 Week High with Significant Volumes

Alivus Life Sciences Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
01 Sep, 20265FINAL01 Sep, 2026Equity Share
01 Sep, 20255FINAL01 Sep, 2025Equity Share
17 Oct, 202322.5INTERIM17 Oct, 2023Equity Share
24 Mar, 202321INTERIM24 Mar, 2023Equity Share
15 Sep, 202210.5FINALEquity Share
22 Nov, 202110.5INTERIM23 Nov, 2021Equity Share

Alivus Life Sciences Stock Comparison

Financials
Price (₹)₹1,605.80₹2,245₹1,192.90₹190.10₹1,314₹987
% Change0.06%0.37%-1.58%-1.28%-1.13%-3.67%
Revenue TTM (₹ Cr)-₹1,559.11₹709.64₹1,931.62₹3,329.63₹2,161.16
Net Profit TTM (₹ Cr)-₹207.02₹188.34₹1,635.75₹707.54₹256.69
PE TTM-66.2072.703.8025.9036.20
1 Year Return62.43110.92104.447.31-17.9744.66
ROCE14.9731.5424.22112.8916.0410.79
Summarize with AI
Google GeminiChatGPTPerplexity AIAnthropic AIGrok AI

FAQ's on ALIVUS

Desktop BannerMobile Banner

Invest Anytime, Anywhere

Get it on Google PlayGet it on App Store

Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy